Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Myocarditis and cardiomyopathy associated with clozapine use in the United States.

Literature DB >> 11463031

Myocarditis and cardiomyopathy associated with clozapine use in the United States.

L La Grenade, D Graham, A Trontell.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2001 PMID： 11463031 DOI： 10.1056/NEJM200107193450317

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

× No keyword cloud information.

29 in total

1. Adverse drug event monitoring at the Food and Drug Administration.

Authors: Syed Rizwanuddin Ahmad
Journal: J Gen Intern Med Date: 2003-01 Impact factor: 5.128

2. Clozapine associated cardiomyopathy: a cluster of 3 cases.

Authors: Carlo Rostagno; Sandro Domenichetti; Francesca Pastorelli; Gian Franco Gensini
Journal: Intern Emerg Med Date: 2010-10-08 Impact factor: 3.397

3. Side effects of atypical antipsychotics: a brief overview.

Authors: Alp Uçok; Wolfgang Gaebel
Journal: World Psychiatry Date: 2008-02 Impact factor: 49.548

4. Dose-Dependent Clozapine-Induced Supraventricular Tachycardia.

Authors: Sutapa Basu
Journal: Prim Care Companion CNS Disord Date: 2016-06-30

Review 5. Clozapine-associated myocarditis: a review of 116 cases of suspected myocarditis associated with the use of clozapine in Australia during 1993-2003.

Authors: Steven J Haas; Richard Hill; Henry Krum; Danny Liew; Andrew Tonkin; Lisa Demos; Karen Stephan; John McNeil
Journal: Drug Saf Date: 2007 Impact factor: 5.606

6. Opposite effects of cannabinoid CB₁ and CB₂ receptors on antipsychotic clozapine-induced cardiotoxicity.

Authors: Liliang Li; Xiaoru Dong; Chunyan Tu; Xiaoqing Li; Zhao Peng; Yiling Zhou; Dingang Zhang; Jieqing Jiang; Allen Burke; Ziqin Zhao; Li Jin; Yan Jiang
Journal: Br J Pharmacol Date: 2019-03-04 Impact factor: 8.739

Review 7. Monitoring the safe use of clozapine: a consensus view from Victoria, Australia.

Authors: Michael Berk; Joanna Fitzsimons; Timothy Lambert; Christos Pantelis; Jayashri Kulkarni; David Castle; Elizabeth W Ryan; Sean Jespersen; Pat McGorry; Gregor Berger; Bill Kuluris; Tom Callaly; Seetal Dodd
Journal: CNS Drugs Date: 2007 Impact factor: 5.749

Myocarditis and cardiomyopathy associated with clozapine use in the United States.

1. Adverse drug event monitoring at the Food and Drug Administration.

2. Clozapine associated cardiomyopathy: a cluster of 3 cases.

3. Side effects of atypical antipsychotics: a brief overview.

4. Dose-Dependent Clozapine-Induced Supraventricular Tachycardia.

Review 5. Clozapine-associated myocarditis: a review of 116 cases of suspected myocarditis associated with the use of clozapine in Australia during 1993-2003.

6. Opposite effects of cannabinoid CB₁ and CB₂ receptors on antipsychotic clozapine-induced cardiotoxicity.

Review 7. Monitoring the safe use of clozapine: a consensus view from Victoria, Australia.

8. Sudden cardiac death due to hypersensitivity myocarditis during clozapine treatment.

Review 9. Drug-induced cardiovascular disorders.

Review 10. Glutamatergic dysfunction in schizophrenia: from basic neuroscience to clinical psychopharmacology.

Myocarditis and cardiomyopathy associated with clozapine use in the United States.

1. Adverse drug event monitoring at the Food and Drug Administration.

2. Clozapine associated cardiomyopathy: a cluster of 3 cases.

3. Side effects of atypical antipsychotics: a brief overview.

4. Dose-Dependent Clozapine-Induced Supraventricular Tachycardia.

Review 5. Clozapine-associated myocarditis: a review of 116 cases of suspected myocarditis associated with the use of clozapine in Australia during 1993-2003.

6. Opposite effects of cannabinoid CB1 and CB2 receptors on antipsychotic clozapine-induced cardiotoxicity.

Review 7. Monitoring the safe use of clozapine: a consensus view from Victoria, Australia.

8. Sudden cardiac death due to hypersensitivity myocarditis during clozapine treatment.

Review 9. Drug-induced cardiovascular disorders.

Review 10. Glutamatergic dysfunction in schizophrenia: from basic neuroscience to clinical psychopharmacology.

6. Opposite effects of cannabinoid CB₁ and CB₂ receptors on antipsychotic clozapine-induced cardiotoxicity.